The receiver operating characteristics curves for 0.5-year overall survival in NLR and PLR patients.

<p>The difference between groups were not statistically significant (<i>P</i> = 0.4704). PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio.</p

Values for total white blood cells, neutrophils, lymphocytes, platelet counts, platelet-to-lymphocyte ratios, and neutrophil-to-lymphocyte ratios in recurrent hepatocellular carcinoma patients (n = 132).

<p>Values for total white blood cells, neutrophils, lymphocytes, platelet counts, platelet-to-lymphocyte ratios, and neutrophil-to-lymphocyte ratios in recurrent hepatocellular carcinoma patients (n = 132).</p

Overall survival curves in low and high platelet-to-lymphocyte ratio patients.

<p>The difference between groups were statistically significant (log-rank test, <i>P</i> = 0.030). PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio.</p

The receiver operating characteristics curves for 2-year overall survival in NLR and PLR.

<p>The difference between groups were not statistically significant (<i>P</i> = 0.7875). PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio.</p

The receiver operating characteristics curves for 1-year overall survival in NLR and PLR patients.

<p>The difference between groups were statistically significant (<i>P</i> = 0.0295). PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio.</p

Overall survival curves in patients with low and high NLR.

<p>The difference between groups were statistically significant (log-rank test, <i>P</i> = 0.017). PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio.</p

Cox proportional hazards model of baseline prognosticators for overall survival in 132 patients with RHCC undergoing TACE.

<p>Cox proportional hazards model of baseline prognosticators for overall survival in 132 patients with RHCC undergoing TACE.</p

Comparison of clinicopathologic and demographic features between patients with low NLR and high NLR expressed as mean ± SD or n.

<p>Comparison of clinicopathologic and demographic features between patients with low NLR and high NLR expressed as mean ± SD or n.</p

Effects of recombinant human IL-21 on the cytokine profiles of tree shrew spleen lymphocytes.

<p>*represents a statistically significant difference between two groups (<i>P</i><0.05).</p

The IL-21 expression in tree shrew samples.

<p>(A) Concentrations of IL-21 in supernatant from tree shrew spleen lymphocytes induced with ConA by ELISA. (B) Quantification of IL-21 mRNA expression in tree shrew spleen lymphocytes induced by ConA. *represents a significant difference compared to stimulation with ConA and the unstimulated negative control (<i>P</i><0.05). (C) The IL-21 expression of tree shrews spleen lymphocytes and human peripheral blood mononuclear cells were detected by flow cytometry staining.</p